Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone with Radiotherapy in Biochemically-relapsing Prostate Cancer
NCT01780220Phase 2Completed
- Sponsor
- Unicancer
- Start
- Dec 2012
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abiraterone in prostate cancer (PCa), sponsored by Unicancer. Started Dec 2012; status: completed.
02
Drugs
abiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01780220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01780220.